JP Patent

JP6835826B2 — Ｌｎａ−ｇプロセス

Assigned to ロシュイノベーションセンターコペンハーゲンエーエス · Expires 2021-02-24 · 5y expired

What this patent protects

Patent listed against eplontersen-sodium.

Drugs covered by this patent

eplontersen-sodium (EPLONTERSEN SODIUM)

Patent Metadata

Patent number: JP6835826B2
Jurisdiction: JP
Classification: —
Expires: 2021-02-24
Drug substance claim: No
Drug product claim: No
Assignee: ロシュイノベーションセンターコペンハーゲンエーエス
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.